Urothelial carcinoma

Disease2 papers

Humans1

Trial sponsors

Roche
Company2 trialsPhase 31,485 people
Mabwell (Shanghai) Bioscience
Company1 trialPhase 3460 people
RemeGen
Company1 trialPhase 3452 people
BeiGene
Company1 trialPhase 3420 people
Seagen
Company1 trialPhase 3412 people
Point Therapeutics
Company1 trialPhase 292 people
Nektar Therapeutics
Company1 trialPhase 1/2557 people
Pfizer
Company1 trialPhase 1540 people

Latest

2

Frontiers in ImmunologyHumans1 Sep

Post-transplant malignancies in Taiwanese kidney transplant recipients: incidence, temporal trends, and immunosuppressive risk factors in a two-decade single-center cohort

BJU InternationalReview24 Aug

Diet and risk of bladder cancer: a systematic review of epidemiological evidence